These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15147434)

  • 1. fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.
    Jardine AG; Holdaas H; Fellström B; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Holme I; Fauchald P; Gimpelwicz C; Pedersen TR;
    Am J Transplant; 2004 Jun; 4(6):988-95. PubMed ID: 15147434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
    Holdaas H; Fellström B; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Solbu DO; Pedersen TR;
    Lancet; 2003 Jun; 361(9374):2024-31. PubMed ID: 12814712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
    Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
    Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
    Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J
    Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data.
    Holdaas H; Fellström B; Holme I; Nyberg G; Fauchald P; Jardine A; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Weinreich T; Olsson AG; Pedersen TR; Benghozi R; Hartmann A;
    J Cardiovasc Risk; 2001 Apr; 8(2):63-71. PubMed ID: 11324372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
    Holdaas H; Fellström B; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Logan JO; Staffler B; Gimpelewicz C;
    Nephrol Dial Transplant; 2005 May; 20(5):974-80. PubMed ID: 15784644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
    Arampatzis CA; Goedhart D; Serruys PW; Saia F; Lemos PA; de Feyter P;
    Am Heart J; 2005 Feb; 149(2):329-35. PubMed ID: 15846273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
    Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
    Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial.
    Liem AH; van Boven AJ; Veeger NJ; Withagen AJ; Robles de Medina RM; Tijssen JG; van Veldhuisen DJ;
    Eur Heart J; 2002 Dec; 23(24):1931-7. PubMed ID: 12473255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN
    Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.
    Holdaas H; Fellström B; Cole E; Nyberg G; Olsson AG; Pedersen TR; Madsen S; Grönhagen-Riska C; Neumayer HH; Maes B; Ambühl P; Hartmann A; Staffler B; Jardine AG;
    Am J Transplant; 2005 Dec; 5(12):2929-36. PubMed ID: 16303007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients.
    Martínez-Castelao A; Grinyó JM; Fiol C; Castiñeiras MJ; Hurtado I; Gil-Vernet S; Serón D; Porta I; Miñarro A; Villarroya A; Alsina J
    Kidney Int Suppl; 1999 Jul; 71():S231-4. PubMed ID: 10412785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
    Serruys PW; de Feyter P; Macaya C; Kokott N; Puel J; Vrolix M; Branzi A; Bertolami MC; Jackson G; Strauss B; Meier B;
    JAMA; 2002 Jun; 287(24):3215-22. PubMed ID: 12076217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation.
    Saia F; de Feyter P; Serruys PW; Lemos PA; Arampatzis CA; Hendrickx GR; Delarche N; Goedhart D; Lesaffre E; Branzi A;
    Am J Cardiol; 2004 Jan; 93(1):92-5. PubMed ID: 14697476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS.
    Lesaffre E; Kocmanová D; Lemos PA; Disco CM; Serruys PW
    Clin Ther; 2003 Sep; 25(9):2431-47. PubMed ID: 14604742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
    Soveri I; Holdaas H; Jardine A; Gimpelewicz C; Staffler B; Fellström B
    Nephrol Dial Transplant; 2006 Aug; 21(8):2282-9. PubMed ID: 16574686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Staffler B; Pedersen TR;
    Transplantation; 2005 Jan; 79(2):205-12. PubMed ID: 15665769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.